The following description is provided to assist the understanding of the reader. None of the information provided or references cited is admitted to be prior art.
Optical coherence tomography (OCT) is an imaging technique. OCT imaging techniques are often used in a medical setting. The techniques are capable of producing three dimensional images from within optical scattering samples, such as biological tissue. In other words, light scattered by a sample can be detected in order to form an image of the sample. When imaging a sample, parts of the sample below its surface can be imaged. Examples of biological tissue that may be imaged using OCT include coronary arteries, skin, and an eye. In another example, OCT may be used for art conservation to analyze layers of a painting.
OCT is often accomplished with the use of an interferometer. An interferometer utilizes light that is reflected back from a sample and a reference light. The reference light is generally configured to travel a similar distance as light that is reflected back from the sample. The light from the sample and the reference light can be combined in such a way that gives rise to an interference pattern. That is, the light from the sample and the reference light will either constructively or destructively interfere with each other. The level of interference that occurs indicates the reflectivity of areas of the sample, such that structures within the sample may be identified and imaged.
In an embodiment, the present technology provides improved flow imaging using an optical coherence tomography (OCT) system. In an illustrative embodiment, the OCT system includes a light source configured to generate a probe beam having an adjustable swept rate and swept range. The OCT system further includes an interferometer and beam scanning optics configured to scan the probe beam onto a sample. The OCT system further includes a detector configured to measure an OCT interference signal returning from the sample. The OCT system further includes a processor configured to generate an OCT image of a flow of the sample. The processor is further configured to scan a B scan of a sample N times at a first slice of the sample. N is greater than or equal to 2. The B scan includes a plurality of A scans. A pixel of the first slice has an M number of A scans within the pixel. Each of the A scans have a spectrum range less than a full spectrum range of the light source. A number of pixels per B scan is an approximate B scan length divided by a lateral resolution size of the pixel. The processor is further configured to determine a flow image of the sample using an optical coherence tomography (OCT) signal reflected back from the sample.
An illustrative method for imaging includes scanning a B scan of a sample N times at a first slice of a sample. N is greater than or equal to 2. The B scan includes a plurality of A scans. A pixel of the first slice has an M number of A scans within the pixel. Each of the A scans have a spectrum range less than a full spectrum range of the light source. A number of pixels per B scan is an approximate B scan length divided by a lateral resolution size of the pixel. The method further includes determine a flow image of the sample using an optical coherence tomography (OCT) signal reflected back from the sample.
An illustrative non-transitory computer readable medium having instructions thereon that, upon execution by a computing device, cause the computing device to perform operations including scanning a B scan of a sample N times at a first slice of a sample. N is greater than or equal to 2. The B scan includes a plurality of A scans. A pixel of the first slice has an M number of A scans within the pixel. Each of the A scans have a spectrum range less than a full spectrum range of the light source. A number of pixels per B scan is an approximate B scan length divided by a lateral resolution size of the pixel. The operations further include determine a flow image of the sample using an optical coherence tomography (OCT) signal reflected back from the sample.
The foregoing summary is illustrative only and is not intended to be in any way limiting. In addition to the illustrative aspects, embodiments, and features described above, further aspects, embodiments, and features will become apparent by reference to the following drawings and the detailed description.
The foregoing and other features of the present disclosure will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. Understanding that these drawings depict only several embodiments in accordance with the disclosure and are, therefore, not to be considered limiting of its scope, the disclosure will be described with additional specificity and detail through use of the accompanying drawings.
In the following detailed description, reference is made to the accompanying drawings, which form a part hereof. In the drawings, similar symbols typically identify similar components, unless context dictates otherwise. The illustrative embodiments described in the detailed description, drawings, and claims are not meant to be limiting. Other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the subject matter presented here. It will be readily understood that the aspects of the present disclosure, as generally described herein, and illustrated in the figures, can be arranged, substituted, combined, and designed in a wide variety of different configurations, all of which are explicitly contemplated and make part of this disclosure.
Described herein is an improved optical coherence tomography (OCT) system for flow imaging, for example, for imaging of blood flow through vessels in the human eye. In many applications, it is valuable to image structures using OCT systems, such as structures within the human eye (e.g., microcirculation in the human ocular fundus). In addition it can be valuable to image fluid flow using OCT systems, such as through blood vessels in the human eye. In various embodiments, improved systems, methods, and computer readable medium are disclosed herein that offer better resolution and/or faster flow imaging, or vascular network imaging in OCT, in addition to simple structural OCT image based on scattering from a sample.
In an ophthalmic application, for example, such flow imaging, or OCT angiography, may be useful for various diagnostics of macular diseases that can be indicated by the macular vascular (blood vessel) network. There are multiple ways to realize such vascular network imaging in OCT. One method is to use Doppler OCT, which detects a Doppler phase shift in OCT signal reflected back from the sample. However, in order to do this with a swept source OCT, a high level of phase stability of the swept source is important to ensure an accurate measurement of the phase shift of the signal returning from the sample. Without high phase stability, noise and/or other inaccuracies may be introduced into an image.
Another way to perform OCT flow imaging is to use speckle variance detection method or amplitude-decorrelation method. In this approach, phase information is not used, which can simplify a hardware configuration of the OCT system including a swept source. Flow or perfusion of blood is detected by OCT signal intensity differentiation (speckle variance) or by amplitude-decorrelation because there is speckle change in the image over time in the presence of flow. For example, demonstration of a speckle variance detection with a swept source OCT system is described in Mariampillai et al., Speckle Variance Detection of Microvasculature Using Swept-Source Optical Coherence Tomography, Optics Letters, Vol. 33 No. 13, Jul. 1, 2008, which is disclosed herein by reference in its entirety. The basic mode of operation is repeating a beam scan at the same location for several times and calculating the speckle variation (or amplitude-decorrelation) that exists when comparing subsequent images.
The full spectrum decorrelation method described in Mariampillai uses repeated B scans at a same location, which can cause a longer time for signal acquisition. Additionally, detection of flow tends to include bulk-motion noise in an axial direction, which can negatively impact the imaging of transverse blood flow, especially in the case of a retinal blood vessel where the axial resolution of an OCT image is higher than a transverse resolution, which makes it more noise-sensitive to any bulk-motion of the vessel or sample itself.
Another method for flow imaging with an OCT system, called split-spectrum amplitude-decorrelation angiography (SSADA) can also be used. An OCT signal returning from a sample can be split using filters such that the spectrum of a single scan is split into several bands. These bands can be used for multiple variations simultaneously, and can relieve some of the issues described above with respect to Mariampillai. In particular, SSADA does not have to include repeat scans of a sample, thus yielding a shorter scan time and effectively reducing the axial resolution without sacrificing speckle variance information. By reducing the axial resolution through this method, the overall decorrelation signal-to-noise ratio (DSNR) can be improved, yielding better quality flow images. Such a method is described in Jia et al, Split-Spectrum Amplitude-Decorrelation Angiography with Optical Coherence Tomography, Optics Express, Vol. 20 No. 4, Feb. 9, 2012 and U.S. Pat. Pub. No. 2014/0228681, both of which are incorporated herein by reference in their entirety.
U.S. Pat. No. 8,500,279, incorporated herein by reference in its entirety, proposes using two different swept source modes, one for a lower resolution mode for previewing an image area before image acquisition, and a second mode for higher resolution with a full spectrum range of the swept source used for image acquisition.
Disclosed herein are systems, methods, and computer readable medium for improved flow imaging. The OCT systems disclosed herein utilize an agile swept source that can vary a swept source rate and a swept source spectrum range very quickly and flexibly. For example, the OCT system may include a tunable VCSEL that allows such functionality that only changes the drive waveform of the system. Thus, quick switching of the swept source can be accomplished.
Utilizing such a swept source in an OCT system, an illustrative vascular network visualization method changes a swept source rate to be M times faster and the swept range (or spectrum) of each scan to be divided by M so that it actually increases a number of A scans (lines) per B scan by M times. The A scans are combined to form a B scan that corresponds to a slice of a sample. In such a method, the system does not have to filter or band pass the returning signal from the sample, because the returning signal is already broken up into additional scans. In addition, the signals can be more easily combined into a flow image because the scans may all be of the same spectrum range. In addition, similar SSADA data processing methods can be used to assemble the image from the returned scan signals.
Because the swept range may be reduced by factor of 1/M, the axial resolution may be increased by M times, while also increasing A lines/scans by M times. In such an approach, each A scan is repeated in the same way so reshaping does not necessarily have to be performed and the spectrum range used covers the same wavelength range over M times, so the full temporal changes in the speckle variance information is not sacrificed. Accordingly, in various embodiments, spectrum ranges less than a full spectrum of a swept light source can be used advantageously as a signal that is sent to a sample for flow imaging. When that signal is reflected back, it can be processed as disclosed herein to yield a flow image that has better resolution and/or is acquired more quickly than a signal acquired using traditional methods or devices.
A high-speed swept-source OCT system 100 comprises a tunable laser 101. The tunable laser 101 may have, for example, a wavelength of 1050 nm with 100 nm tuning range, a tuning cycle with a repetition rate of up to 400 kHz and a duty cycle of 50%. Other configurations of an OCT system may also be used in various embodiments. Light from the swept source 101, or a probe beam, is coupled into a two by two fiber coupler 102 through single mode optical fiber. As disclosed herein, the swept source generates a signal or probe beam that has an adjustable swept rate and swept range. The OCT system 100 also includes an interferometer and beam scanning optics configured to scan the probe beam onto a sample. Accordingly, one portion of the light proceeds to the sample arm (i.e., the patient interface), and the other portion of the light can proceed to the reference arm.
In the sample arm, a sample arm polarization control unit 103 can be used to adjust light polarization state. The exit light from the fiber coupler 102 is coupled with a retinal scanner whereby the light is collimated by sample arm collimating lens 104 and reflected by mirror 105 and two dimensional galvo scanner 109 (e.g., an XY galvonanometer scanner). Two lenses, first lens 106 (e.g., an objective lens) and second lens 107 (e.g., an ocular lens), relay probe beam reflected by galvo scanner 109 into a human eye 108, although other body parts or things may be scanned also. For example, a focused spot diameter of 18 μm (full-width-half-maximum amplitude profile) can be calculated on the retinal plane based on an eye model. The average light power (i.e., output power of the laser) onto human eye can be 1.9 mW, which is consistent with safe ocular exposure limit set by the American National Standard Institute (ANSI).
The reference arm can comprise a first reference arm collimating lens 113, a water cell 112, a retro-reflector 111, a glass plate 114 and a second reference arm collimating lens 115. The glass plate 114 can be used to balance the dispersion between the OCT sample arm and reference arm. Water cell 112 compensates the influence of dispersion in the human eye 108. The retro-reflector 111 is mounted on a translation stage 110 that can be moved to adjust the path length in the reference arm.
Light from sample and reference arm interfere at beam splitter 117. A reference arm polarization control unit 116 is used to adjust the beam polarization state in the reference arm to maximum interference signal. The optical interference signal from beam splitter 117 is detected by a balanced detector 118, sampled by an analog digital conversion unit 119 and transferred into computer 120 for processing. For example, computer 120 can be used for storing instruction for and implementing the methods described herein. The computer 120 include a processor configured to carry out various processing functions, such as those described herein to generate a flow image. The processor can carry out processing functions according to instructions stored on a memory of the computer 120 or otherwise connected to the computer 120. The memory may be non-transitory computer readable medium having instructions thereon that, upon execution by a computing device or processor, cause the computing device or processor to perform operations. Such operations may include the various processing and/or methods disclosed herein. The memory and instructions thereon may also be executed by a processor to control other aspects of the OCT system 100, such as the swept source. As disclosed herein, the swept source can be switched to perform different imaging modes, resolutions, and/or scan times. Accordingly, the processor and computer 120 may control the various aspects of the OCT system 100 to affect such modes and methods.
One way to achieve this resolution modification is band-pass filtering of the spectral interferogram (e.g., band-pass filtering 210). However, this sacrifices speckle information in the spectral interferogram and decreases the flow signal. Another way to decrease axial resolution that does not lose as much speckle information is to split the spectrum into different frequency bands (e.g., split-spectrum 215) and calculate decorrelation in each band separately. The decorrelation (flow) images from the multiple spectral bands can then be averaged together to make full use of the speckle information in the entire OCT spectrum. The lower half of
Also shown is a full bandwidth scan 305, similar to the one described above with respect to the split spectrum method of
In this embodiment, the B scan 315 is shown scanning a sample N times at a first slice of the sample. More than one B scan can be performed, such that N is greater than or equal to 2, but only one B scan 315 is actually shown in
This determination of the flow image may be done in a number of ways as disclosed herein. For example, the system can determine the flow image by performing speckle variance detection or amplitude-decorrelation of the OCT signal between corresponding A scans of the same spectrum range within a pixel. The system can also determine the flow image by performing speckle variance detection or amplitude-decorrelation of the OCT signal of the M number of A scans. In some embodiments, the system can determine the flow image by performing speckle variance detection or amplitude-decorrelation of the OCT signal between the consecutive N B scans at the pixel. In yet another example, the system may determine the flow image by averaging speckle variance detection or amplitude-decorrelation of the OCT signal over the M A scans of the pixel and/or over consecutive N B scans at the pixel.
An illustrative formula for performing speckle variance is shown below as Equation 2:
Each of these formulas, as well as other methods, may be used to determine a flow image based on the OCT signals reflected back from a sample using the methods, systems, and computer readable medium disclosed herein.
The foregoing description of illustrative embodiments has been presented for purposes of illustration and of description. It is not intended to be exhaustive or limiting with respect to the precise form disclosed, and modifications and variations are possible in light of the above teachings or may be acquired from practice of the disclosed embodiments.
While certain embodiments have been illustrated and described, it should be understood that changes and modifications can be made therein in accordance with ordinary skill in the art without departing from the technology in its broader aspects as defined in the following claims.
The embodiments, illustratively described herein may suitably be practiced in the absence of any element or elements, limitation or limitations, not specifically disclosed herein. Thus, for example, the terms “comprising,” “including,” “containing,” etc. shall be read expansively and without limitation. Additionally, the terms and expressions employed herein have been used as terms of description and not of limitation, and there is no intention in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the claimed technology. Additionally, the phrase “consisting essentially of” will be understood to include those elements specifically recited and those additional elements that do not materially affect the basic and novel characteristics of the claimed technology. The phrase “consisting of” excludes any element not specified.
The present disclosure is not to be limited in terms of the particular embodiments described in this application. Many modifications and variations can be made without departing from its spirit and scope, as will be apparent to those skilled in the art. Functionally equivalent methods and compositions within the scope of the disclosure, in addition to those enumerated herein, will be apparent to those skilled in the art from the foregoing descriptions. Such modifications and variations are intended to fall within the scope of the appended claims. The present disclosure is to be limited only by the terms of the appended claims, along with the full scope of equivalents to which such claims are entitled. It is to be understood that this disclosure is not limited to particular methods, reagents, compounds compositions or biological systems, which can of course vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
As will be understood by one skilled in the art, for any and all purposes, particularly in terms of providing a written description, all ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. As will also be understood by one skilled in the art all language such as “up to,” “at least,” “greater than,” “less than,” and the like, include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, as will be understood by one skilled in the art, a range includes each individual member.
All publications, patent applications, issued patents, and other documents referred to in this specification are herein incorporated by reference as if each individual publication, patent application, issued patent, or other document was specifically and individually indicated to be incorporated by reference in its entirety. Definitions that are contained in text incorporated by reference are excluded to the extent that they contradict definitions in this disclosure.
Other embodiments are set forth in the following claims.
Number | Name | Date | Kind |
---|---|---|---|
4466699 | Droessler et al. | Aug 1984 | A |
5022745 | Zayhowski et al. | Jun 1991 | A |
5319668 | Luecke | Jun 1994 | A |
5372135 | Mendelson et al. | Dec 1994 | A |
5430574 | Tehrani | Jul 1995 | A |
5537162 | Hellmuth et al. | Jul 1996 | A |
5561523 | Blomberg et al. | Oct 1996 | A |
5982963 | Feng et al. | Nov 1999 | A |
6070093 | Oosta et al. | May 2000 | A |
6111645 | Tearney et al. | Aug 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6275718 | Lempert | Aug 2001 | B1 |
6282011 | Tearney et al. | Aug 2001 | B1 |
6373632 | Flanders | Apr 2002 | B1 |
6421164 | Tearney et al. | Jul 2002 | B2 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6564087 | Pitris et al. | May 2003 | B1 |
6725073 | Motamedi et al. | Apr 2004 | B1 |
7099358 | Chong | Aug 2006 | B1 |
7231243 | Tearney et al. | Jun 2007 | B2 |
7323680 | Chong | Jan 2008 | B2 |
7324214 | De Groot et al. | Jan 2008 | B2 |
7352783 | Chong | Apr 2008 | B2 |
7382809 | Chong et al. | Jun 2008 | B2 |
7388891 | Uehara et al. | Jun 2008 | B2 |
7400410 | Baker et al. | Jul 2008 | B2 |
7414779 | Huber et al. | Aug 2008 | B2 |
7428057 | De Lega et al. | Sep 2008 | B2 |
7489713 | Chong et al. | Feb 2009 | B2 |
7701588 | Chong | Apr 2010 | B2 |
7725169 | Boppart et al. | May 2010 | B2 |
7835010 | Morosawa et al. | Nov 2010 | B2 |
7865231 | Tearney et al. | Jan 2011 | B2 |
7869057 | De Groot | Jan 2011 | B2 |
7884945 | Srinivasan et al. | Feb 2011 | B2 |
7961312 | Lipson et al. | Jun 2011 | B2 |
8036727 | Schurman et al. | Oct 2011 | B2 |
8115934 | Boppart et al. | Feb 2012 | B2 |
8315282 | Huber et al. | Nov 2012 | B2 |
8405834 | Srinivasan et al. | Mar 2013 | B2 |
8500279 | Everett et al. | Aug 2013 | B2 |
8625104 | Izatt et al. | Jan 2014 | B2 |
8690328 | Chong | Apr 2014 | B1 |
8690330 | Hacker et al. | Apr 2014 | B2 |
9163930 | Buckland et al. | Oct 2015 | B2 |
20020163948 | Yoshida et al. | Nov 2002 | A1 |
20050171438 | Chen et al. | Aug 2005 | A1 |
20050201432 | Uehara et al. | Sep 2005 | A1 |
20050213103 | Everett et al. | Sep 2005 | A1 |
20060105209 | Thyroff et al. | May 2006 | A1 |
20060109872 | Sanders | May 2006 | A1 |
20060215713 | Flanders et al. | Sep 2006 | A1 |
20070040033 | Rosenberg | Feb 2007 | A1 |
20070076217 | Baker et al. | Apr 2007 | A1 |
20070081166 | Brown et al. | Apr 2007 | A1 |
20070133647 | Daiber | Jun 2007 | A1 |
20070141418 | Ota et al. | Jun 2007 | A1 |
20070263226 | Kurtz et al. | Nov 2007 | A1 |
20070291277 | Everett et al. | Dec 2007 | A1 |
20080097194 | Milner | Apr 2008 | A1 |
20080269575 | Iddan | Oct 2008 | A1 |
20090022181 | Atkins et al. | Jan 2009 | A1 |
20090103050 | Michaels et al. | Apr 2009 | A1 |
20090169928 | Nishimura et al. | Jul 2009 | A1 |
20090247853 | Debreczeny | Oct 2009 | A1 |
20090268020 | Buckland et al. | Oct 2009 | A1 |
20090290613 | Zheng et al. | Nov 2009 | A1 |
20100157308 | Xie | Jun 2010 | A1 |
20100246612 | Shimizu | Sep 2010 | A1 |
20100284021 | Hacker | Nov 2010 | A1 |
20110112385 | Aalders | May 2011 | A1 |
20110235045 | Koerner | Sep 2011 | A1 |
20110255054 | Hacker et al. | Oct 2011 | A1 |
20110299034 | Walsh et al. | Dec 2011 | A1 |
20120026466 | Zhou et al. | Feb 2012 | A1 |
20120136259 | Milner et al. | May 2012 | A1 |
20120188555 | Izatt et al. | Jul 2012 | A1 |
20140051952 | Reichgott et al. | Feb 2014 | A1 |
20140111774 | Komine | Apr 2014 | A1 |
20140228681 | Jia et al. | Aug 2014 | A1 |
20140268163 | Milner et al. | Sep 2014 | A1 |
20140293290 | Kulkarni | Oct 2014 | A1 |
20140336479 | Ando | Nov 2014 | A1 |
20150348287 | Yi et al. | Dec 2015 | A1 |
20160178346 | Kulkarni | Jun 2016 | A1 |
20170090031 | Bondy et al. | Mar 2017 | A1 |
20180128594 | Lee et al. | May 2018 | A1 |
Number | Date | Country |
---|---|---|
10 2011 114 797 | Apr 2013 | DE |
2006-202543 | Aug 2006 | JP |
2008-188047 | Aug 2008 | JP |
2010-172538 | Aug 2010 | JP |
2010-540914 | Dec 2010 | JP |
WO-2012075126 | Jun 2012 | WO |
WO-2013168149 | Nov 2013 | WO |
WO-2015121756 | Aug 2015 | WO |
Entry |
---|
Changho Chong, et al. “Large Coherence Length Swept Source for Axial Length Measurement of the Eye.” Applied Optics 48:10 (2009): D145-150. |
Chowdhury, Md Koushik et al., Challenges & Countermeasures in Optical Noninvasive Blood Glucose Detection, International Journal of Innovative Research in Science, Engineering and Technology vol. 2, Issue 1, Jan. 2013 (6 pages). |
Dai et al., “Optical coherence tomography for whole eye segment imaging,” Optics Express, vol. 20, No. 6 (2012) pp. 6109-6115. |
Dhalla et al., “Simultaneous swept source optical coherence tomography of the anterior segment and retina using coherence revival,” Optics Letters, vol. 37 No. 11, Jun. 1, 2012, pp. 1883-1885. |
English Translation of the International Search Report and Written Opinion on International Application No. PCT/EP2009/009189, dated Apr. 6, 2010, 12 pages. |
F. Lexer et al., “Wavelength-tuning interferometry of intraocular distances,” Applied Optics, vol. 36, No. 25, pp. 6548-6553 (Sep. 1, 1997). |
Fainman, Y. et al., “Nanophotonics for Information Systems,” Information Optics and Photonics (T. Fournel and B. Javidi eds., Springer New York, 2010) pp. 13-37. |
International Search Report and Written Opinion dated Aug. 26, 2015 for PCT/US15/32727 (8 pages). |
International Search Report and Written Opinion in International Application No. PCT/US2015/19299 dated Nov. 2, 2015 (10 pages). |
International Search Report and Written Opinion in PCT/IB2015/000808 dated Oct. 20, 2015 (12 pages). |
Jeong et al., “Spectral-domain OCT with dual illumination and interlaced detection for simultaneous anterior segment and retina imaging,” Optics Express, vol. 20, Issue 17, pp. 19148-19159 (2012). |
Jeong et al., Spectral-domain 1-13 OCT with dual illumination and interlaced detection for simultaneous anterior segment and retina imaging, Optics Express, vol. 20 No. 17, dated Aug. 13, 2012, pp. 19148-19159. |
Jia et al., Split-Spectrum Amplitude-Decorrelation Angiography with Optical Coherence Tomography, Optics Express, vol. 20 No. 4, Feb. 9, 2012, pp. 4710-4725. |
Lexer et al., “Wavelength-tuning interferometry of intraocular distances”, Applied Optics, vol. 36, No. 25, Sep. 1, 1997, pp. 6548-6553. |
Mariampillai et al., Speckle Variance Detection of Microvasculature Using Swept-Source Optical Coherence Tomography, Optics Letters, vol. 33 No. 13, Jul. 1, 2008, pp. 1530-1532. |
Nankivil et al., FFD01CHandheld, rapidly switchable, anterior/posterior segment swept source optical coherence tomography probe,FFD01D OSA Nov. 1, 2015; vol. 6, No. 11; DOI:10.1364/BOE.6.004516; Biomedical Optics Express 4516-4528. |
P. Tayebati et al., “Microelectromechanical tunable filter with stable half symmetric cavity,” Electronics Letters, vol. 34, No. 20, pp. 1967-1968 (Oct. 1, 1998). |
Sarlet, G. et al., “Wavelength and Mode Stabilization of Widely Tunable SG-DBR and SSG-DBR Lasers,” IEEE Photonics Technology Letters, vol. 11, No. 11, Nov. 1999, pp. 1351-1353. |
Segawa, Toru et al., “Semiconductor Double-Ring-Resonator-Coupled Tunable Laser for Wavelength Routing,” IEEE Journal of Quantum Electronics, vol. 45, No. 7, Jul. 2009, pp. 892-899. |
Sergie Ortiz, et al. “Corneal Topography From Spectral Optical Coherence Tomography (SOCT).” Biomedical Optics Express 2:12, (2011):3232-3247. |
U.S. Office Action dated Sep. 12, 2013. |
U.S. Office Action on U.S. Appl. No. 14/723,325 dated Nov. 18, 2016. |
International Preliminary Report on Patentability in corresponding international application No. PCT/US2015/019299 dated Sep. 22, 2016. |
International Preliminary Report on Patentability in corresponding international application No. PCT/US2015/032727 dated Dec. 8, 2016. |
International Preliminary Report on Patentability in International appln. No. PCT/IB2015/000808. |
International Search Report and Written Opinion in corresponding application No. PCT/US2016/035012 dated Aug. 18, 2016. |
U.S. Notice of Allowance on 105093-0102 dated Dec. 6, 2013. |
U.S. Notice of Allowance on U.S. Appl. No. 14/601,945 dated Sep. 13, 2016. |
U.S. Notice of Allowance on U.S. Appl. No. 14/613,644 dated Nov. 7, 2016. |
U.S. Notice of Allowance on U.S. Appl. No. 14/613,644 dated Nov. 18, 2016. |
U.S. Notice of Allowance on U.S. Appl. No. 14/641,200 dated Jul. 12, 2016. |
U.S. Office Action dated Aug. 19, 2015. |
U.S. Office Action on U.S. Appl. No. 14/601,945 dated Mar. 2, 2016. |
U.S. Office Action on U.S. Appl. No. 14/613,644 dated Jun. 8, 2016. |
U.S. Office Action on U.S. Appl. No. 14/641,200 dated Mar. 14, 2016. |
U.S. Office Action on U.S. Appl. No. 14/641,200 dated Dec. 7, 2015. |
U.S. Office Action on U.S. Appl. No. 14/723,325 dated Apr. 24, 2017. |
U.S. Office Action on U.S. Appl. No. 15/202,925 dated Jul. 27, 2017. |
Chopra et al., Topographical Thickness of the Skin in the Human Face, Aesthetic Surgery Journal, vol. 35(8), 2015, pp. 1007-1013. |
Final Office Action on U.S. Appl. No. 14/723,325 dated Jul. 26, 2018. |
International Preliminary Report on Patentability on International Application No. PCT/US2016/035012 dated Dec. 14, 2017 (11 pages). |
Non-Final Office Action on U.S. Appl. No. 15/086,520 dated Aug. 6, 2018. |
Non-Final Office Action on U.S. Appl. No. 15/139,579 dated Jul. 17, 2018. |
Non-Final Office Action on U.S. Appl. No. 15/648,239 dated Jun. 6, 2018. |
Non-Final Rejection Office Action on U.S. Appl. No. 14/723,325 dated Dec. 7, 2017 (11 pages). |
Poddar, et al., “Non-Invasive Glucose Monitoring Techniques: A Review and Current Trends,” Oct. 2008, pp. 1-47. |
U.S. Notice of Allowance on U.S. Appl. No. 15/202,925 dated May 17, 2018. |
U.S. Office Action on U.S. Appl. No. 15/630,654 dated Apr. 4, 2018. |
Number | Date | Country | |
---|---|---|---|
20180344149 A1 | Dec 2018 | US |